envafolimab – Talk Bio

Actionable Insights Powered by AI

TRACON Pharmaceuticals Discontinues Envafolimab Development, Explores Strategic Options

TRACON Pharmaceuticals, Envafolimab, Oncology, Clinical Trial, Strategic Options, Mergers, Acquisitions, Asset Sales